Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daily fluticasone versus episodic salmeterol/fluticasone in children with recurrent wheezing
TCTR20180614002Phase 4Completed
- Sponsor
- Queen Sirikit National Institute of Child Health
- Start
- Sep 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fluticasone propionate, salmeterol + fluticasone in wheeze, asthma, sponsored by Queen Sirikit National Institute of Child Health. Started Sep 2016; status: completed.
02
Drugs
fluticasone propionatesalmeterol + fluticasone
03
Conditions
wheezeasthma
Beyond the preview
Go deeper on TCTR20180614002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180614002.